This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of suspected haemolytic transfusion reaction

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Immediate investigations:

  • double check labelling of the blood unit with the patient's ID band
  • take 40 ml of blood:
    • blood bank (5ml anticoagulated; 5 ml clotted)
    • clinical chemistry (10 ml electrolytes)
    • coagulation laboratory (10 ml coagulation screen)
    • bacteriology (blood culture)
  • ECG - look for evidence of hyperkalaemia
  • Repeat coagulation screens and biochemistry 2-4 hourly

Immediate management:

  • stop transfusion
  • keep iv access open (0.9% NaCl)
  • the unconscious patient requires a urinary catheter
  • frusemide (150 mg iv)
  • saline 100-200 ml
  • give mannitol (20%) 100 ml if there is no diuresis after frusemide
  • insert CVP line - maintain CVP +5 to + 10 cm water with 0.9% NaCl

Further management:

  • if urine flow < 100ml/h after 2 hours then assume renal failure and consult nephrologist
  • if there is a urine flow > 100ml/h then adjust infusion rate to maintain this
  • if hyperkalaemia treat as appropriate
  • if DIC treat as appropriate

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.